We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Ngm Biopharmaceuticals Inc
7 own
7 watching
Current Price
$0
$0.04
(0.76%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
428.18M
52-Week High
18.25
52-Week Low
2.92
Average Volume
0.11M
Dividend Yield
--
P/E Ratio
--
Market Capitalization428.18M52-Week High18.2552-Week Low2.92Average Volume0.11MDividend Yield--P/E Ratio--What does the Ngm Biopharmaceuticals Inc do?
NGM Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases. The company's product candidates include NGM282, an engineered variant of the FGF19 human hormone in Phase 2 clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); NGM313, an agonistic antibody that selectively activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase 1b early proof-of-concept clinical trials for use in the treatment of type 2 diabetes and NASH; and NGM386 and NGM395, which are engineered variants of the GDF15 human hormone for use in the treatment of obesity. Its products under development also comprise NGM120, an antagonistic antibody binding glial cell-derived neurotrophic factor receptor alpha-like that is in Phase 1 clinical trials to inhibit the effects of elevated GDF15 levels on cancer anorexia/cachexia syndrome; NGM217, an antibody in Phase 1 clinical trials to restore pancreatic islet function and increase insulin production in patients with diabetes; and NGM621, an antibody in preclinical studies to decrease levels of a protein implicated in the dry form of age-related macular degeneration. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp., MedImmune Limited, and JDRF International. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Read More
How much money does Ngm Biopharmaceuticals Inc make?
News & Events about Ngm Biopharmaceuticals Inc.
Ticker Report
7days ago
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM Get Rating) Director Group L. P. Column purchased 37,639 shares of NGM Biopharmaceuticals stock in a transaction dated Thursday, January 19th. The stock was bought at an average cost of $5.00 per share, with a total value of $188,195.00. Following the...
Globe Newswire
20days ago
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, and ...
Globe Newswire
23days ago
NGM Bios three-pronged corporate strategy includes the following components: Focus internal clinical development efforts on solid tumor oncology portfolioGenerate next-generation biologics through prolific in-house discovery engineSeek partners for other NGM-discovered programs including aldafermin...
Globe Newswire
2 months ago
Poster presentation to showcase initial data from the Phase 1a monotherapy dose escalation arm of the ongoing Phase 1/2 trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, in patients with advanced solid tumorsILT2 and ILT4, both upregulated in certain tumor types, are believed ...
Globe Newswire
2 months ago
--Poster presentation to showcase NGM Bios in vitro and in vivo research supporting development of NGM936, a ILT3 x CD3 bispecific T cell engager product candidate engineered to direct T cell-mediated killing of ILT3-positive cancer cells-- --Oral presentation from the lab of Dr. Fabiana Pernaat the...
Frequently Asked Questions
Frequently Asked Questions
What is Ngm Biopharmaceuticals Inc share price today?
Can Indians buy Ngm Biopharmaceuticals Inc shares?
How can I buy Ngm Biopharmaceuticals Inc shares from India?
Can Fractional shares of Ngm Biopharmaceuticals Inc be purchased?
What are the documents required to start investing in Ngm Biopharmaceuticals Inc stocks?
What is today’s traded volume of Ngm Biopharmaceuticals Inc?
What is today’s market capitalisation of Ngm Biopharmaceuticals Inc?
What is the 52-Week High and Low Range of Ngm Biopharmaceuticals Inc?
What percentage is Ngm Biopharmaceuticals Inc down from its 52-Week High?
What percentage is Ngm Biopharmaceuticals Inc up from its 52-Week Low?
Current Price
$0
$0.04
(0.76%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.